Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference

Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference

Reuters - 58 minutes ago
Includes Clinical Data for XL147, XL765 and XL139 SOUTH SAN FRANCISCO, Calif.--(Business Wire)-- Exelixis, Inc. (Nasdaq: EXEL) announced today that thirteen abstracts related to the company`s ...